ethanol intake by SR 141716, an antagonist of central cannabinoid
(CB1) receptors. Psychopharmacology (Berl.) 132, 104–106.
Basavarajappa B. S., Saito M., Cooper T. B. and Hungund B. L. (2000)
Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol
by chronic ethanol and its modulation by specific neuromodulators
in cerebellar granule neurons. Biochim. Biophys. Acta 1535,
78–86.
Basavarajappa B. S., Saito M., Cooper T. B. and Hungund B. L. (2003)
Chronic ethanol inhibits the anandamide transport and increases
extracellular anandamide levels in cerebellar granule neurons.
Eur. J. Pharmacol. 466, 73–83.
Basavarajappa B. S., Yalamanchili R., Cravatt B. F., Cooper T. B. and
Hungund B. L. (2006) Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout
mice. Neuropharmacology 50, 834–844.
Baskfield C. Y., Martin B. R. and Wiley J. L. (2004) Differential effects
of delta-9-tetrahydrocannabinol and methanandamide on operant
behavior in CB1 knockout and wild type mice. J. Pharmacol. Exp.
Ther. 309, 86–91.
Blednov Y. A., Jung S., Alva H., Wallace D., Rosahl T., Whiting P. J.
and Harris R. .H. (2003) Deletion of the a1 or b2 subunit of
GABAA receptors Reduces actions of alcohol and other drugs.
J. Pharmacol. Exp. Ther. 304, 30–36.
Buck K. J. and Hood H. M. (1998) Genetic association of a GABAA
receptor 2 subunit variant with severity of acute physiological
dependence on alcohol. Mamm. Genome 9, 975–978.
Cohen C., Perrault G., Voltz C., Steinberg R. and Soubrie P. (2002)
SR141716, a central cannabinoid (CB(1)) receptor antagonist,
blocks the motivational and dopamine-releasing effects of nicotine
in rats. Behav. Pharmacol. 13, 451–463.
Colombo G., Agabio R. and Fa M. (1998) Reduction of voluntary
ethanol intake in ethanol-preferring sP rats by the cannabinoid
antagonist SR-141716. Alcohol Alcohol. 33, 126–130.
Comings D. E., Muhleman D., Gade R., Johnson P., Verde R.,
Saucier G. and MacMurray J. (1997) Cannabinoid receptor gene
(CNR1): association with i.v. drug use. Mol. Psychiatry 2, 161–
168.
Crabbe J. C. and Phillips T.J. (2004) Pharmacogenetic studies of alcohol
self-administration and withdrawal. Psychopharmacology (Berl.)
174, 539–560.
Crestani F., Lorez M., Baer K., Essrich C., Benke D., Laurent J. P.,
Belzung C., Fritschy J. M., Luscher B. and Mohler H. (1999)
Decreased GABAA-receptor clustering results in enhanced anxiety
and a bias for threat cues. Nat. Neurosci. 2, 833–839.
Criswell H. E., Johnson K. B., Mueller R. A. and Breese G. R. (1993)
Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid
antagonist MK-801 in control and 6-hydroxydopamine-lesioned
rats. J. Pharmacol. Exp. Ther. 265, 1001–1010.
De Witte P. (2004) Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol. Addict. Behav.
29, 1325–1339.
Faingold C. L., N'Gouemo P. and Riaz A. (1998) Ethanol and neurotransmitter interactions-from molecular to integrative effects. Prog.
Neurobiol. 55, 509–535.
Floyd D. W., Jung K. Y. and McCool B. A. (2003) Chronic ethanol
ingestion facilitates N-methyl-D-aspartate receptor function and
expression in rat lateral/basolateral amygdala neurons. J. Pharmacol. Exp. Ther. 307, 1020–1029.
Gallate J. E. and McGregor I. S. (1999) The motivation for beer in rats:
effects of ritanserin, naloxone and SR 141716. Psychopharmacology (Berl.) 142, 302–308.
Gallate J. E., Saharov T., Mallet P. E. and McGregor I. S. (1999)
Increased motivation for beer in rats following administration of a
